{"id":"NCT03078855","sponsor":"Jonathan Friedberg","briefTitle":"A Study to Evaluate the Effect of Vitamin D on PFS in Indolent Non-Hodgkin's Lymphoma","officialTitle":"ILyAD (Indolent Lymphoma And Vitamin D) A Phase III Double Blind, Randomized Trial to Evaluate the Effect of Vitamin D on Progression-free Survival in Patients With Low Tumor-burden Indolent Non-Hodgkin Lymphoma Treated With Rituximab","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-09-07","primaryCompletion":"2023-07-21","completion":"2024-07-02","firstPosted":"2017-03-13","resultsPosted":"2024-09-04","lastUpdate":"2024-09-04"},"enrollment":211,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"SUPPORTIVE_CARE"},"conditions":["Follicular Lymphoma","Small Lymphocytic Lymphoma","Marginal Zone Lymphoma","Mucosal-Associated Lymphoid Tissue Lymphoma"],"interventions":[{"type":"DIETARY_SUPPLEMENT","name":"Vitamin D","otherNames":["Cholecalciferol"]},{"type":"BIOLOGICAL","name":"Rituximab","otherNames":["Rituxan"]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"Vitamin D plus rituximab","type":"EXPERIMENTAL"},{"label":"Placebo plus rituximab","type":"PLACEBO_COMPARATOR"}],"summary":"Despite strong evidence suggesting that vitamin D deficiency is associated with undesirable outcomes in patients with numerous cancers, there has never been a thorough study of vitamin D treatment in subjects undergoing treatment for cancer. The purpose of this study is to evaluate whether modification of vitamin D levels in the blood, through supplementation, can improve outcomes.","primaryOutcome":{"measure":"Event Free Survival","timeFrame":"3 years","effectByArm":[{"arm":"Vitamin D Plus Rituximab","deltaMin":47.7,"sd":null},{"arm":"Placebo Plus Rituximab","deltaMin":49.5,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.26"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":6},"locations":{"siteCount":7,"countries":["United States"]},"refs":{"pmids":["39677358"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":16,"n":135},"commonTop":["Infusion related reaction","Fatigue","Headache","Injection site reaction","Other - COVID19"]}}